<DOC>
	<DOCNO>NCT01065259</DOCNO>
	<brief_summary>The objective study compare effect Concerta ( Osmotic Release Oral System Extended Release Methylphenidate HCL , OROS MPH ) Strattera ( Atomoxetine ) laboratory ecological executive function child attention deficit hyperactivity disorder .</brief_summary>
	<brief_title>Concerta Strattera Executive Function Attention Deficit Hyperactivity Disorder ( ADHD ) Children</brief_title>
	<detailed_description>The sample include 134 ADHD child adolescence , randomize assign Concerta strattera treatment group , 67 case . It also include 67 sex age match normal control . The drug titrate optimal dose . The executive function include inhibition , work memory , set shifting plan compare among two medication group control group , use laboratory executive function test Behavior Rating Inventory Executive Function ( BRIEF ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Age 6 16 year old . Body weight 20 60 kg Meet ADHD criterion tne Diagnostic Statistic Manual Mental Disorders , fourth edition ( DSMIV ) questionaire interview Intelligence quotient ( IQ ) &gt; = 70 Currently unmedicated effectively medicate immediately release methylphenidate ( The maximum dosage 60mg/d ) The patient parent express comply follow include clinical interview test The parent guardian sign write consent Can swallow capsule Have administer immediate release methylphenidate , OROS MPH atomoxetine , ADHD symptoms improve . Bipolar I II disorder , psychosis , pervasive developmental disorder . Meet DSMIV anxiety disorder . Any seizure disorder ( except febrile convulsion ) electroencephalogram ( EEG ) abnormal associate epilepsy , currently take anticonvulsion drug . Depression disorder , tend commit suicide , comorbid depression symptom need immediate treatment . Tics disorder , Tourette 's syndrom（DSMIV 307.23） , family history tic disorder . Narrowangle glaucoma cardiovascular disease , disease may deteriorate pulse blood pressure increase , include hypertension take antihypertension drug . Diseases significantly enhance sympathetic nervous system activity , take sympathomimetic drug every day . Allergic methylphenidate atomoxetine , serious allergic reaction one drug adverse event multiple drug . Serious gastrointestinal stenosis History alcohol , drug substance abuse Those use unprescribed potential abuse drug screen . In process trial , patient need take psychotropic drug experimental drug , include health food central nervous system ( CNS ) activity ( e.g . melatonin ) . Might begin structure psychological therapy address ADHD process trial Have use psychotropic drug past 30 day , include monoamine oxidase inhibitor . Are participate clinical trial . Have difficulty follow 8 week . Relatives investigator . Employee Xian Jensen Eli lilly company .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>attention deficit hyperactivity disorder</keyword>
	<keyword>executive function</keyword>
	<keyword>OROS MPH</keyword>
	<keyword>atomoxetine</keyword>
</DOC>